EMD-11997

Single-particle
3.7 Å
EMD-11997 Deposition: 01/12/2020
Map released: 13/01/2021
Last modified: 13/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-11997

Archive Files (Depositor)

Primary 3D volume (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-7b3y summary report (pdf.gz) Map-7b3y FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

Structure of a nanoparticle for a COVID-19 vaccine candidate

EMD-11997

Single-particle
3.7 Å
EMD-11997 Deposition: 01/12/2020
Map released: 13/01/2021
Last modified: 13/11/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Human immunodeficiency virus 1, Thermotoga maritima (strain ATCC 43589 / MSB8 / DSM 3109 / JCM 10099)
Sample: RBD-Spycatcher-mi3
Fitted models: 7b3y

Deposition Authors: Duyvesteyn HME , Stuart DI
A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses.
PUBMED: 33483491
DOI: doi:10.1038/s41467-020-20654-7
ISSN: 2041-1723
Grant Support: